HighPoint Advisor Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
16,552
-867
-5% -$57K 0.04% 311
2026
Q1
$1.24M Sell
17,419
-34,908
-67% -$2.75M 0.05% 253
2025
Q4
$4.29M Buy
52,327
+18,895
+57% +$1.47M 0.09% 194
2025
Q3
$2.51M Sell
33,432
-16,670
-33% -$1.24M 0.12% 135
2025
Q2
$3.71M Buy
50,102
+17,509
+54% +$1.22M 0.2% 89
2025
Q1
$2.22M Sell
32,593
-4,547
-12% -$391K 0.13% 132
2024
Q4
$3.07M Sell
37,140
-380
-1% -$32.3K 0.17% 109
2024
Q3
$3.52M Sell
37,520
-15,289
-29% -$1.28M 0.21% 89
2024
Q2
$4.37M Buy
52,809
+38,028
+257% +$3.1M 0.26% 71
2024
Q1
$1.2M Buy
14,781
+1,771
+14% +$147K 0.08% 186
2023
Q4
$1.15M Buy
+13,010
New +$911K 0.08% 197

Other funds holding GEHC

HighPoint Advisor Group's GEHC Position: Q2 2026 in Review

HighPoint Advisor Group reduced its GE HealthCare (GEHC) stake by 5% in Q2 2026, selling an estimated $57K and leaving 16,552 shares worth $1.06M. The position accounts for 0.04% of the portfolio, ranked #311.

HighPoint Advisor Group first reported a position in GEHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.37M in Q2 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • HighPoint Advisor Group held 16,552 shares of GE HealthCare worth $1.06M as of Q2 2026.
  • HighPoint Advisor Group sold 867 GE HealthCare shares in Q2 2026, an estimated $57K.
  • GE HealthCare made up 0.04% of HighPoint Advisor Group's portfolio in Q2 2026, its #311 holding.
  • HighPoint Advisor Group first reported a position in GE HealthCare in Q4 2023 and has held it in 11 quarters since.
  • HighPoint Advisor Group's GE HealthCare position peaked at $4.37M in Q2 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.